INBX vs PYPL · rev $1.3M vs P/E 7.9, rev $33.17B
Inhibrx Biosciences, Inc. (INBX) versus PayPal Holdings Inc (PYPL) — a side-by-side from cached financials, not a winner call.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Alex Chriss.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
INBX currently screens at market cap $1.28B. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Not investment advice. Open the INBX and PYPL stock pages for the full models.
Not investment advice.